Managing IP is part of the Delinian Group, Delinian Limited, 8 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 00954730
Copyright © Delinian Limited and its affiliated companies 2023

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Singapore: Analysing the ASEAN Patentscope project

The Association of Southeast Asian Nations (ASEAN) has launched the ASEAN Patentscope making up-to-date online ASEAN patent data available to patent search firms, patent attorneys and innovators seeking to commercialise their innovations in the ASEAN region.

The ASEAN Patentscope project was started by the ASEAN Patent Examination Cooperation (ASPEC) Task Force in 2012 to enhance regional collaboration on research and development (R&D) activities and to encourage technological development among ASEAN countries. For the first time, a regional ASEAN patent database service has been made available to the public. Indonesia has contributed extensively to the project by hosting the regional patent database server. Singapore also played a leadership role to initiate the project through its chairmanship of the ASPEC Task Force.

The availability of online patent data brings government services closer to innovators by removing barriers of distance and paper searching to access quality technology resources. The ASEAN Patentscope can be accessed using the link at

The ASEAN Patentscope provides a number of powerful tools and features to assist users. These include bibliographic data search, view of published patent dossier information, search results in a customisable report, and translations into national languages. By simply entering a term or a phrase in English, it is possible to retrieve relevant patent documents, country-level patent filings by technology sector and related patent family information in the region.

The move builds on the ongoing ASEAN-WIPO collaboration to leverage WIPO software to support ASEAN innovation. This initiative will enable ASEAN to step up the innovation ladder and encourage innovators in the region to use the patent system for enhanced participation in regional and global business.

ASEAN doubled its share of the world's scientific literature from 1.37% (2006) to 2.43% (2015) according to the Asian Scientist (2016) with Malaysia, Brunei and Vietnam sharply increasing their output of research papers. WIPO statistics also indicate that patents in ASEAN have increased more than 40% from 2012 to 2016.

The ASEAN Patentscope was developed in a framework which is modern and effective and should make a substantial contribution to enhancing access to ASEAN regional patent information.


Daniel Collopy

Spruson & Ferguson (Asia) Pte Ltd

152 Beach Road

#37-05/06 Gateway East

Singapore 189721

Tel: +65 6333 7200

Fax: +65 6333 7222

more from across site and ros bottom lb

More from across our site

IP counsel urge the government to restrict safe harbour exceptions available to intermediaries and clear up doubts with the existing law
A New York lawyer could face sanctions after citing fake judgments generated by ChatGPT, but that doesn’t mean practitioners should shy away from AI
Klaus Grabinski told delegates at a UPC inauguration event that the proposed SEP regulation would limit access to justice
We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere in IP
Sukanya Sarkar shares her thoughts on this year’s annual meeting in Singapore, where debates ranged from AI opportunities to improving law firm culture
The court’s ruling is a good reminder that US parties aren’t guaranteed attorney fees just because they win, say sources
With business confidence in a shaky state, Rachel Tan and Lisa Yong of Rouse discuss how in-house IP teams can manage their trademark portfolios through uncertain times
The Court of Appeal had stern words for Med-El’s representatives after they highlighted a deputy judge’s background as a solicitor
Funders and NPEs say asserting patent portfolios can minimise risk at the USPTO’s PTAB, where procedure remains a controversial topic
The US Supreme Court’s ruling wasn’t a surprise and reflects a trend that had already been bubbling away for a while, say tech and pharma counsel